Insider Stock Trading History of Bergstein Ivan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bergstein Ivan since year 2005. The trader's CIK number is 1554767. At the time of this reporting, Bergstein Ivan is the Chief Executive Officer of Stemline Therapeutics Inc . (stock ticker symbol STML). See this page for all insider trading activities at Stemline Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Bergstein Ivan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-03-12 STML Stemline Therapeutics Inc Sale 2,151 11.05 23,768
2019-03-11 STML Stemline Therapeutics Inc Sale 55,073 11.11 611,861
2019-03-07 STML Stemline Therapeutics Inc Sale 6,800 11.41 77,588
2019-02-25 STML Stemline Therapeutics Inc Sale 22,905 12.03 275,547
2019-02-14 STML Stemline Therapeutics Inc Sale 34,132 10.98 374,769
2018-03-12 STML Stemline Therapeutics Inc Sale 37,857 17.68 669,122
2018-03-07 STML Stemline Therapeutics Inc Sale 6,797 16.56 112,558
2018-02-26 STML Stemline Therapeutics Inc Sale 10,776 17.61 189,765
2018-02-27 STML Stemline Therapeutics Inc Sale 13,407 17.26 231,404
2018-02-15 STML Stemline Therapeutics Inc Sale 3,820 15.80 60,356
2017-03-07 STML Stemline Therapeutics Inc Sale 5,401 8.13 43,910
2017-02-27 STML Stemline Therapeutics Inc Sale 7,500 6.97 52,275
2017-02-28 STML Stemline Therapeutics Inc Sale 10,480 7.01 73,464
2017-02-16 STML Stemline Therapeutics Inc Sale 3,652 6.42 23,445
2016-03-08 STML Stemline Therapeutics Inc Sale 5,537 5.34 29,567
2016-02-17 STML Stemline Therapeutics Inc Sale 3,244 4.46 14,468
2015-11-30 STML Stemline Therapeutics Inc Sale 12,235 8.20 100,326
2015-02-18 STML Stemline Therapeutics Inc Sale 3,180 14.02 44,583
2014-11-26 STML Stemline Therapeutics Inc Sale 11,974 14.40 172,425
2014-09-03 STML Stemline Therapeutics Inc Buy 2,000 11.05 22,108

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bergstein Ivan (Chief Executive Officer of Stemline Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.